Twelve-month outcomes of a bioabsorbable implant for in-office treatment of dynamic nasal valve collapse.

ABSTRACT: OBJECTIVES:To examine 12-month outcomes for in-office treatment of dynamic nasal valve collapse (NVC) with a bioabsorbable implant. STUDY DESIGN:Prospective, multicenter, nonrandomized study. METHODS:One hundred sixty-six patients with severe-to-extreme class of Nasal Obstruction Symptom Evaluation (NOSE) scores were enrolled at 16 U.S. clinics (November 2016-July 2017). Patients were treated with a bioabsorbable implant (Latera, Spirox Inc., Redwood City, CA) to support the lateral wall, with or without concurrent inferior turbinate reduction (ITR), in an office setting. NOSE scores and Visual Analog Scale (VAS) were measured at baseline and 1, 3, 6, and 12 months postoperatively. The Lateral Wall Insufficiency (LWI) score was determined by independent physicians observing the lateral wal

SUBMITTER: Sidle DM 

PROVIDER: S-EPMC7217163 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature